 |
Clonidine |
|---|---|
| Trade Name | Duraclon |
| Orphan Indication | For continous epidural administration as adjunctive therapy with intraspinal opiates for the treatment of pain in cancer patients tolerant to, or unresponsive to, intraspinal opiates |
| USA Market Approval | USA |
| USA Designation Date | 1989-01-24 00:00:00 |
| Sponsor | Roxane Laboratories, Inc.;PO Box 16532;Columbus, Ohio, 43216 |
